艾美捷科技代理Affinity Immuno品牌。

Affinity Immuno（AffinityImmuno）是一家位于加拿大的生物技术公司，一直专注于为生物药物研究提供高质量的试剂和服务。该公司以其专业的技术背景和丰富的产品线，在生物仿制药和单抗药研究领域赢得了广泛的认可，广泛应用于学术研究、生物技术和制药公司的研究工作。

AffinityImmuno产品包括：

（1）ELISA试剂盒：

AffinityImmuno生产的ELISA试剂盒具有高灵敏度、特异性和可重复性，用于测定临床前和临床血清血浆样本中的抗体药浓度，以及进行免疫学相关检测。这些试剂盒可用于检测多种疾病，如癌症、自身免疫病和感染病等。

（2）抗体：

公司提供多种抗体产品，包括针对癌症、自身免疫和内分泌疾病的新型靶点的抗体，以及用于细胞去除、阻断和激活研究的单克隆抗体。AffinityImmuno还可根据客户要求进行定制化开发，如多克隆抗体的制备。

（3）研发支持服务：

除了产品销售外，AffinityImmuno还提供高质量的研发支持服务，包括抗体发现、蛋白质工程和检测开发等。这些服务旨在帮助客户加速生物药物的研发进程，提高研发效率和质量。

PhosphoSolutions成立于2001年，由Drs. Michael D. Browning, John W. Haycock, and Andrew J. Czernik 等一同创立，已发展成为在神经科学领域的蛋白及抗体的领先供应商。

PhosphoSolutions was founded in 2001 by Drs. Michael D. Browning, John W. Haycock, and Andrew J. Czernik who all worked together in the laboratory of Dr. Paul Greengard, co-recipient of the 2000 Nobel Prize in Medicine for his work on the role of protein phosphorylation in signal transduction in the nervous system. This expertise has led us to focus primarily on proteins of interest in the neuroscience field.

PhosphoSolutions公司的主要产品包括：

Cardiovascular

Catecholamine Signaling

Cell Markers

Cytoskeletal and Nuclear Proteins

DNA Damage

Extracellular Matrix Proteins

GABA Receptors

Glutamate Receptors and Associated Signaling Proteins

Hormone Biosynthesis

Neurodegenerative Disease

Neurogenesis and Development

Neurotransmission

Oncoproteins

RNA Processing

Signal Transduction

Steroid Hormone Receptors

Synaptic Vesicle Proteins

Uncategorized

Visual System

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

Allele Biotechnology位于美国圣地亚哥市，主要专注于对生物过程的机制进行探索，以开发生物医学及治疗相关的技术和产品。以各个物种的iPS细胞、人类cGMP iPS细胞及衍生的细胞为材料，Allele Biotechnology利用专利性的非整合细胞编辑方法，开发了出了细胞治疗和药物筛选的技术。Allele Biotechnology具有深厚的基因组修饰和细胞荧光报告因子的经验，为客户提供优异的细胞检测解决方案。Allele Biotechnology还提供荧光蛋白、高效荧光素酶底物、基因分型试剂盒、骆驼抗体等产品；此外还在RNA干扰领域尤其独特的专利。

Allele Biotechnology and Pharmaceuticals, Inc. is a private, San Diego-based company that explores the mechanisms of biological processes to develop technologies and products for biomedical research and therapy development.

Our mission is to increase accessibility to innovative molecular biology research tools by offering cutting edge technologies in individual products and fully integrated platforms. Allele utilizes proprietary non-integrating cellular reprogramming methods to develop cell therapy and enable drug discovery through the use of human and non-human primate iPS cells, cGMP-grade human iPS cells and their derivatives. With additional expertise in genome modification and unique cell-based fluorescence sensors/reporters, Allele provides advanced cell and assay development solutions. Allele also has developed a wide variety of advanced research tools including superior fluorescent proteins, highly efficient luciferase assay substrates, genotyping kits, and camelid antibodies that have been validated for co-immunoprecipitation, histology, and flow cytometry. The Company has also been a leader in the RNAi field with its patents in Pol III promoter-driven siRNA, shRNA, and miRNA.